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Overall Abstract (word count=250) 
 
Background: Depressed mood in pregnancy has been linked to low birthweight (LBW), a risk 
factor for adult-onset chronic diseases in offspring. 
Objective: Examine maternal depressed mood in relation to birthweight and evaluate the role of 
DNA methylation at regulatory sequences of imprinted genes in this association.  
Methods: We measured depressed mood among 922 pregnant women using the CES-D scale and 
obtained birthweight data from hospital records. Using bisulfite pyrosequencing of cord blood 
DNA from 508 infants, we measured methylation at differentially methylated regions (DMRs) 
regulating imprinted genes IGF2/H19, DLK1/MEG3, MEST, PEG3, PEG10/SGCE, NNAT and 
PLAGL1. Multiple regression models were used to examine the relationship between depressed 
mood, birthweight and DMR methylation levels.  
Results: Severe depressed mood was associated with a >3-fold higher risk of LBW (birthweight 
<2500grams) (OR 3.6, 95% CI 1.1-11.4) after adjusting for delivery mode, parity, education, 
cigarette smoking, folic acid use, and preterm birth. The association may be more pronounced in 
offspring of Black women (OR 7.2, 95% CI 1.8-28.7) and female infants (OR 7.5, 95% CI 1.5-
38.9). Compared to infants of women without depressed mood, infants born to women with 
severe depressed mood had a 2.4% higher methylation at the MEG3 DMR (p=0.02). Whereas 
LBW infants had 1.6% (p=0.06) lower methylation at the IGF2 DMR, high birthweight 
(>4500grams) infants had 5.9% (p=0.02) higher methylation at PLAGL1 DMR compared to 
normal birthweight infants.  
Conclusion: Our findings confirm that severe maternal depressed mood in pregnancy I 
associated with LBW, and MEG3 and IGF2 plasticity may play important roles. 
 
 Systematic Review: Depression during Pregnancy and Poor Birth Outcomes  
Abstract 
Context: Maternal depression during pregnancy, a common problem with substantial morbidity, 
has been associated with poor birth outcomes that may predispose to chronic diseases in 
adulthood.  Both depression and poor birth outcomes are more common in minority groups, 
which may contribute to disparities in health. 
Objective: To estimate the risk of poor birth outcomes (low birth weight, preterm birth, small 
for gestational age) associated with maternal prenatal depression and whether this association 
differs among racial/ethnic groups. 
Data Sources: We searched the MEDLINE, PsychInfo, and Cochrane databases between Oct 
17th, 2011 and Jan. 13th, 2012, limiting studies to English language and dates 1990-present. 
Search terms included maternal depression, major depressive episode, NOT postpartum 
depression, pregnancy outcomes, Low Birth Weight, Preterm Birth, Prenatal Exposure, Race, 
Ethnicity, African-American, Black, Hispanic, using MeSH terms when possible.  Additional 
articles were included based on bibliographic searches of relevant reviews.  
Study Selection: Cohort studies, both community and clinic-based, that examined the exposure 
of depression (measured using clinical diagnosis or validated scale) and the outcomes of low 
birth weight, preterm birth, or small for gestational age compared to a control group of non-
depressed women were included in this study.  Studies were limited to those conducted in the 
U.S. with at least 50% of the study population consisting of minorities. 
Data Abstraction: One reviewer abstracted data into standardized data tables, which included 
information about study characteristics and results. The same reviewer performed quality 
assessments based on standardized criteria to evaluate potential for bias and external validity.  
 Data Synthesis: A total of 318 abstracts were screened and 37 articles underwent full review of 
which 8 articles describing 8 studies were included in this review. 6 out of 8 studies found an 
association between depression/depressive symptoms in pregnancy and poor birth outcomes. 
Studies were limited by small sample size, heterogenous measures of the exposure, different 
definitions for the outcomes, and the observational nature of the studies that prevent 
establishment of causation due to multiple possible confounders. 
Conclusions: We found limited evidence for a mild association between depression/depressive 
symptoms in pregnancy and poor birth outcomes. There is insufficient evidence to determine if 
this association differs among different racial/ethnic groups. More research is needed, 
particularly in minority groups, to further explore this association and elucidate any differences 
by race/ethnicity. 
 
 
 
 
 
 
 
 
 
 
 
 
 Introduction 
 Depression during pregnancy is a common problem with substantial morbidity for both 
mother and child.1 Estimates of the prevalence of depression in the prenatal period range from 
10-15% of women, with one review estimating that 12.7% of pregnant women undergo a major 
depressive episode during their pregnancy.2 This prevalence may be higher in African-American 
and Hispanic pregnant women, with over half showing depressive symptoms during the prenatal 
period. 3   Some experts hypothesize that this may be related to more stress and negative life 
events and fewer sources of social support for minority pregnant women.  
 In addition to depression causing harm to the mother during pregnancy, there may be 
added harm to the child with potential long term effects.  There is growing support for the 
developmental origins of disease hypothesis which postulates that the prenatal environment and 
in utero exposures can affect disease susceptibility in adulthood. 4 Over 25 years ago, 
epidemiological data from England and Wales revealed an association between geographical 
areas with high infant mortality and areas with high rates of cardiovascular disease.4, 5  Since 
most of the infant mortality was attributable to low birth weight, it was hypothesized that 
undernutrition and growth restriction in utero may result in metabolic and physiological changes 
that could increase susceptibility to cardiovascular disease in adulthood.    
Since then, studies describing the survivors of the Dutch winter of hunger 1944-456, 7 and 
survivors of the Chinese famine of 1959-618, 9 have found that those exposed to famine in utero 
have increased rates of poor birth outcomes, obesity, dyslipidemia, hypertension, and 
schizophrenia/affective disease. Although exact mechanisms of these associations are unknown, 
epigenetic changes that alter hormonal regulation and the hypothalamus-pituitary-adrenal (HPA) 
axis have been proposed.10 Epigenetic markers are established early in gestation, and metabolic 
 perturbations in the early environment may result in persistent changes in the epigenome that can 
increase disease susceptibility in adulthood.11 Growing evidence suggests that poor birth 
outcomes such as low birth weight (LBW) and preterm birth (PTB) may be reflections of 
conditions during pregnancy and that these poor birth outcomes are associated with later chronic 
disease such as coronary heart disease, stroke, metabolic syndrome/type II diabetes, and 
osteoporosis.12 
 Moreover, in addition to the disparities that exist with respect to the prevalence of 
depression in minority women, there are also disparities present when examining birth outcomes 
by race/ethnicity. The infant mortality rate (IMR) in 2007 for Non-Hispanic Blacks was 
13.31/1000 births compared to 5.63/1000 births in Non-Hispanic Whites. The majority of this 
difference can be attributed to disparities in rates of LBW and PTB between the two groups.13  
Race has been proposed as an independent risk factor for poor birth outcomes, and psychosocial 
determinants of health, such as depression and stress, have also been implicated in this 
association.14 Geronimus proposed the “weathering” hypothesis which states that African-
American women undergo additional stress and health deterioration due to repeated and 
cumulative social, economic, and political exclusion. 15 He found that among Blacks, but not 
Whites, advancing maternal age above 15 years is associated with increased odds of LBW 
suggesting that psychosocial weathering may be associated with poor birth outcomes in Blacks.16 
Understanding psychosocial determinants of health such as stress and depression may be integral 
in combating disparities in birth outcomes for minority women. 
Current evidence suggests that psychosocial risk factors including depression may affect 
birth outcomes. ACOG (American Congress of Obstetricians and Gynecologists) has issued a 
statement emphasizing the importance of screening for psychosocial risk factors such as 
 depression and elevated stress during pregnancy to prevent poor birth outcomes.17 A systematic 
review conducted in 2007 concluded that the majority of the studies showed an overall 
association between depressive symptoms during pregnancy and negative obstetric, fetal, and 
neonatal outcomes. However, the authors noted that their review was limited by variations in the 
timing and instrument used to measure the exposure as well as incomplete assessment of relevant 
confounders.18 A subsequent review in 2012 found that although the evidence is limited, there 
may be an independent association between depression during pregnancy and poor birth 
outcomes.19 Their review examined a limited number of studies and focused mainly on 
differences between medicated and unmedicated women.  No review to date has examined this 
association in diverse populations to assess if differences exist across race/ethnicity. 
Depression is a common problem in pregnancy that may contribute to substantial 
morbidity during and after pregnancy for both mother and child. Epidemiological evidence 
suggests that in utero exposures, such as depression, may affect birth outcomes and chronic 
disease later in life. Reviews of the current literature, although limited, do suggest an association 
between maternal depression in pregnancy and poor birth outcomes. Although evidence suggests 
that minority women experience higher rates of depression during pregnancy and higher 
incidences of poor birth outcomes, no review to date has fully assessed potential differences in 
the association between maternal prenatal depression and the poor birth outcomes of low birth 
weight, preterm birth, and small for gestational age among groups by race/ethnicity.  
This review seeks to systematically examine the evidence surrounding the association 
between depression in pregnancy, measured using clinical diagnosis or validated scale, and the 
outcomes of preterm birth, low birth weight, and small for gestational age as compared to non-
depressed women.  In particular, we will focus on studies with a diverse population conducted in 
 the U.S. in order to elucidate any differences in this association by race/ethnicity, which may 
contribute to disparities in birth outcomes. Specifically, we seek to answer the following 
questions: What is the association between prenatal depression during pregnancy and poor birth 
outcomes, including preterm birth (PTB), low birth weight (LBW), and small for gestational age 
(SGA), compared to non-depressed pregnant women in diverse populations?  Is there a 
difference in this association across race/ethnicity, and is the association greater for African-
American and Hispanic women, which may contribute to disparities in birth outcomes among 
minority women? 
 
Table 1: PICOTTS-Eligibility Criteria 
 Eligibility Criteria 
Population: 
 
Participants are pregnant women prior to delivery 
• Limited to Studies in the U.S. with at least 50% minority women 
 
Intervention
/Exposure 
Assesses exposure of prenatal depression using clinical diagnosis from interview, 
self-reported diagnosis or validated scale to measure depressive symptoms   
• Depression assessed prospectively, prior to outcome of interest 
• Will accept retrospective abstraction of medical records for a diagnosis of 
depression if depression was assessed prior to outcome 
 
Comparator 
 
Has a group of non-depressed pregnant women as a comparator 
Outcomes Primary outcomes of interest are preterm birth (PTB) and low birth weight 
(LBW) or a combination of birthweight adjusted for gestational age/SGA 
• Abstracted from medical records by trained personnel after birth or self-
reported with validation from medical records 
• Study quantifies risk of poor birth outcome using a quantitative measure 
(ex. Odds ratio, beta coefficient…etc.) 
 
Timing 
 
Limited to studies between 1990-January 2012 and English Language 
Study Type 
 
Limited to cohort studies (community and clinic-based) 
 
 
 Methods: 
Literature Search 
We searched the Medline, PsychInfo, and general Cochrane databases from October 17th, 
2011 to January 13th, 2012. Search terms included maternal depression, major depressive 
episode, NOT postpartum depression, pregnancy outcomes, Low Birth Weight, Preterm Birth, 
Prenatal Exposure, Race, Ethnicity, African-American, Black, Hispanic, using MeSH terms 
when possible. We also reviewed bibliographies from relevant systematic and narrative reviews.  
In addition, we used Web of Science to examine the citation web for the oldest accepted article 
(Steer et al. 20) examining this association.  Studies were limited to those between 1990 and 
present and published in English language. 
Study Selection/Eligibility 
A single reviewer (YL) conducted initial screening of all the titles and abstracts generated 
by the search using the above eligibility criteria (Table 1) to find an initial group of relevant 
studies.  The single reviewer then reviewed the full-text of these initial articles using the same 
eligibility criteria to determine the final studies to be included in this review.  We chose to limit 
studies to the U.S. because of the unique racial make-up and history that may contribute to 
disparities in health among different racial/ethnic groups.  We also limited our review to studies 
that included greater than 50% minorities so that the sample size would be sufficient to examine 
any differences in the association between maternal depression in pregnancy and poor birth 
outcomes among different racial/ethnic groups. 
Data Extraction and Management 
All citations were imported into EndNote X3 for management and review.  Data from 
included studies were abstracted by a single reviewer into standardized tables containing 
 information about the study design, study population, exposure, primary and secondary 
outcomes, and any race/ethnicity – specific outcomes.  
Quality Assessment (individual studies) 
Quality was assessed by one reviewer (YL) using standardized criteria for assessing the 
potential for bias and for degree of external validity based on guidelines (CRD) to grade 
individual studies: poor, fair or good.  Studies were graded based on four quality areas describing 
risk of bias/internal validity: quality of study design (reporting, loss to follow-up, comparability 
of control and exposure group), quality of exposure measurement, quality of outcome 
assessment, quality of analysis (power, adjustment for confounders, quantifies risk), and one 
quality area assessing external validity/generalizability.  Each of the five criteria was graded 
(good, fair, poor) and reasons were each grade were given in standardized abstraction forms.  An 
overall good study had a grade of good for at least four of the five categories with no grades of 
poor.  Fair studies had a grade of good for at least one of the five categories with no grades of 
poor.  All other studies and those with a fatal flaw were classified as poor.   
Grading of the Strength of the Evidence (Body of Studies) 
Once all the individual studies were compiled and graded, the overall strength of the 
evidence was assessed using the criteria of aggregate risk of bias/internal validity, consistency, 
directness, and precision. 21 The principal summary measure analyzed was the odds ratio or risk 
ratio that quantified added risk of poor birth outcome associated with the exposure of prenatal 
maternal depression. 
 
 
 
 Results 
Study Selection 
Figure 1 shows the flowchart for the study selection process. 256 titles were obtained 
from the MEDLINE, PsychInfo and the Cochrane database searches.  An additional 53 titles 
were obtained from the references of relevant reviews and articles for a total of 318 
abstracts/titles that were screened.  Of those, 282 were excluded due to being duplicates or not 
meeting inclusion criteria, and 37 underwent full-text review.  Of those, 29 were excluded due to 
assessing a different exposure (n=10), insufficient minority population (n=2), having been 
conducted outside the U.S. (n=11), and assessing only intermediate outcomes (n=6).  In total, 8 
published articles from 8 studies were included in the final systematic review. 
Study Characteristics 
Table 1 shows the study characteristics from the eight studies included in this review. All 
eight of the studies were conducted in the US and were published in English. Six of the eight 
were prospective cohort studies.20, 22-26 One was a retrospective cohort study using data 
abstracted from medical records,27 and the other was a nested retrospective cohort study within 
the Black Women’s Health Study.28 All studies examined pregnant women during gestation with 
six studies examining only adult women22-26, 28, one examining only adolescent women27, and 
one examining both.20 Six of the studies examined women from multiple racial/ethnic where the 
majority of women were from minority groups.20, 22-24, 26, 27 Two studies examined African-
American women only.25, 28 Four studies used validated scales to measure depressive symptoms 
including the Centers for Epidemiological Studies Depression Scale (CES-D) and the Beck 
Depression Inventory (BDI).20, 25, 26, 28 Three studies used a combination of clinical diagnosis and 
validated scale for assessing depression/depressive symptoms22-24, and one study used a four-
 question non-validated questionnaire.27  All studies assessed the exposure prior to the outcome, 
most during the 2nd trimester, with two studies repeating the assessment during the third 
trimester. 23, 24   One study assessed the exposure at enrollment but did not specify the exact 
times during gestation.28 All studies included a comparator group of non-depressed women. Five 
of the studies assessed the outcomes of birth weight and gestational age20, 22-24, 27, while three 
studies focused on preterm birth only.25, 26, 28 Of note, four studies specifically excluded women 
taking medications or receiving treatment for depression,22-24, 27 and none of the studies 
examined the effect of antidepressants on birth outcomes. In summary, most of the trials were 
prospective cohort trials of moderate sample size that assessed exposure and outcome using 
validated methods and accounted for multiple possible confounders. 
Risk of Bias within Studies 
Table 2 shows quality ratings based on internal validity and external validity for all 
studies included in this review. Four studies were given a grade of “good” after being assessed 
for risk of bias/internal validity and external validity.20, 23, 25, 26  These studies were all 
prospective cohort trials with good reporting and minimal loss to follow-up. The exposure was 
measured using a validated scale or clinical diagnosis prior to the outcome, and the outcomes 
were abstracted by trained personnel after delivery. All used multivariate models that adjusted 
for multiple possible confounders and had large sample sizes and adequate power. All had 
reasonable eligibility criteria and fair generalizability.  Given our inclusion criteria and focus on 
this association in minority groups, generalizability to the population as a whole is limited. Four 
studies were graded as either fair or poor.22, 24, 27, 28 The fair study was limited by a small sample 
size and poor generalizability, although methodology was sound.22  Poor studies either collected 
outcomes data retrospectively or had poor reporting of methodology, and all had a fatal flaw. In 
 one study, the exposure was assessed using a non-validated questionnaire27, and in two studies, 
the outcome was either defined using non-conventional methods or assessed using self-reported 
responses with minimal validation with medical records.24, 28 Overall, the studies were of fair 
quality, with four given a good rating, one a fair rating, and three a poor rating with fatal flaws. 
Synthesis of Results 
Six of the studies found increased risk of poor birth outcomes (lower birth weight or 
shorter gestational age) for women with depression/depressive symptoms during pregnancy as 
compared to women without depression/depressive symptoms.20, 23-27 The magnitude of this 
difference ranged from 1-2 gestational weeks and 200-300 grams of birth weight. Odds ratios for 
the association between depression in pregnancy and preterm birth ranged from 2-3 fold 
increases. Odds ratios for the association between depression in pregnancy and low birth weight 
or small for gestational age ranged from 3-4 fold increases. One study found borderline 
associations between maternal depression and low birth weight and preterm birth.22 Another 
study found no association after adjustment for multiple maternal variables including maternal 
age, martial status, education, BMI, smoking, parity and comorbid conditions. 28 Overall, most of 
the studies did find a mild to moderate association between depression/depressive symptoms in 
pregnancy and poor birth outcomes (LBW, PTB, SGA). 
Results Related to Ethnicity/Race 
Two studies specifically examined the possible modification effect of race/ethnicity on 
the association between depression/depressive symptoms in pregnancy and poor birth outcomes. 
Hodgkinson et al. stratified by race when examining this association, but found no differences.27 
Orr et al. noticed that the association between depression/depressive symptoms and poor birth 
outcomes was limited to the African-American women in their sample.26  However, the 
 interaction term of depression and race/ethnicity was not significant in their logistic regression 
models. In addition, the two studies that only examined African-American women give 
conflicting results. Orr et al. conducted a prospective cohort study of 1399 women and found an 
association between depressive symptoms in pregnancy (measured by CES-D score stratified at 
the 10th percentile) and spontaneous preterm birth, OR 1.96 (95% CI 1.04-3.72).25 Phillips et al. 
conducted a retrospective cohort study from medical records for 2627 women and also used the 
CES-D scale to measure depressive symptoms, but they defined spontaneous preterm birth using 
self-reported responses of being three or more weeks early.28 They found that a CES-D scale 
score >33 was associated with spontaneous preterm birth with odds ratio 2.0 (95% CI 0.94-4.25), 
p=0.09. Overall, there is insufficient evidence to determine if this association varies by 
race/ethnicity, and existing evidence is conflicting. 
Overall Assessment of Evidence 
There is moderate risk of bias in the reviewed studies. Although the overall quality of the 
studies was fair to good, the nature of observational studies makes them susceptible to bias and 
confounders that may not have been fully assessed. The studies are moderately consistent as six 
out of eight studies found an association between depression/depressive symptoms and poor birth 
outcomes. The two studies that did not find an association were of fair/poor quality and limited 
by poor characterization of the exposure and outcome and small sample size. The directness of 
the link between the exposure and the outcome is minimal as there are multiple possible 
confounders involved, and observational studies are unable to fully assess causation. The 
precision of the studies are moderate as estimates of the risk are within similar ranges across 
studies; however, the confidence intervals surrounding these estimates are relatively broad. In 
addition, only two studies specifically examined the effect of race/ethnicity in this association, 
 and both reported that no significant effect in their sample. Moreover, the two studies conducted 
in African-American populations are conflicting. The generalizability of these studies to the US 
population as a whole is only fair. Most of these studies were conducted in urban settings with a 
high proportion of minorities. Overall, there is limited evidence suggesting a mild association 
between depression/depressive symptoms and poor birth outcomes in diverse populations in the 
US. There is insufficient evidence to determine if this effect is different in African-American 
women.  
 
Discussion 
Summary of Evidence 
This review examined eight studies that met our inclusion criteria. Most of these studies 
used either a validated scale or clinical diagnosis of depression/depressive symptoms and 
assessed depression during the 2nd trimester, with two studies repeating this assessment in the 
third trimester.  Almost all studies abstracted birth outcomes data from medical records, but two 
used self-reported outcomes after birth. Sample sizes varied, but most of the studies were large 
with adequate power and measured/adjusted for multiple possible confounders. Due to the urban 
nature of most of these studies and high percentage of minority women, the generalizability to 
the overall population as a whole is fair.  
Of these studies, six found a significant association between depression/depressive 
symptoms during pregnancy and poor birth outcomes including low birth weight, preterm birth, 
and small for gestational age. The magnitude of this association ranged from a 2-4 fold increase 
in risk for poor birth outcome associated with depression.  Differences in gestational age and 
birth weight between women with depression/depressive symptoms and women without ranged 
 from 1-2 weeks and 200-300g of birth weight. Only two studies assessed effects of race/ethnicity 
through stratification or adding cross-product terms to the multivariate model, but neither study 
found race to be a significant effect modifier of this association. The two studies conducted in 
African-American only populations are conflicting. Overall, there is limited evidence to suggest 
a mild association between depression/depressive symptoms and poor birth outcomes. There is 
insufficient evidence to determine if this association varies between different racial/ethnic 
groups. 
Additional Studies 
 Two other studies examined the association between depression/depressive symptoms 
and birth outcomes and the possible role of race/ethnicity and socio-economic class; however, 
neither met our inclusion criteria. Hoffman and Hatch studied a cohort of 666 pregnant women in 
New York and Pennsylvania, and stratified them by socioeconomic status (SES) using 
occupational status scores stratified at a score of 50.29 Because they did not describe the 
racial/ethnic make-up of their cohort, they were excluded from our review. They assessed 
psychological well being in all three trimesters using the CES-D scale, Life Events Scale, 
Fischer's Social Network Interview, and the External Locus of Control and Chance Scale, and 
measured the outcomes of birth weight and gestational age abstracted from medical records. 
They found that in low SES women only, a one-point increase on the CES-D scale at 28wks was 
associated with 9.1g reduction in gestational-age adjusted birth weight that was still significant 
after adjustment for multiple confounders. This association was not significant in high SES 
women or for depressive symptoms in any other trimester. In addition, Field et al. studied a 
cohort of 86 pregnant minority women, 54% Hispanic and 46% AA, and also stratified by SES 
using the Hollingshead Four-factor Index of social status.  They assessed mood during pregnancy 
 using the CES-D and the Profile of Mood States (POMS) scales, and then they measured fetal 
activity, physiology, and behavior. They found differences between the groups by race/ethnicity 
and SES, suggesting that both variables are important in associations between maternal 
psychosocial condition and infant/fetal profiles.30 
Limitations 
 There are many limitations to these studies examining associations between psychosocial 
risk factors and birth outcomes. The greatest is the inability to determine causation due to the 
epidemiological nature of these studies and the inability to adjust for all possible confounders. In 
addition, it is difficult to fully assess depression/depressive symptoms because there are many 
contributing factors such as stress, anxiety, social support, and life events that contribute to 
morbidity. Other complex variables that are difficult to assess, such as socioeconomic factors, 
income, education, neighborhoods, attitudes, and social context, may also be involved in this 
association.  
 The studies reviewed are limited by the use of multiple different measures of 
depression/depressive symptoms at different times in pregnancy. Many did not repeat 
measurements. Although studies have shown that depression/depressive symptoms measured in 
one trimester of pregnancy is consistent throughout,24 some studies have found that the 
association between depression and poor birth outcomes was limited to a specific trimester.29 
There was also heterogeneity among outcomes measured. Some studies examined only preterm 
birth, categorized as either spontaneous or medically-indicated, while others also examined low 
birth weight and small for gestational age. Sample size varied considerably, and some studies 
were limited by inadequate power.  
 In addition, studies examining race/ethnicity are limited by the heterogeneity of many 
groups and the difficultly of properly defining and characterizing groups. Although all studies 
were diverse (>50% minority women), only two studies explicitly studied the effect of 
race/ethnicity on associations between depression/depressive symptoms in pregnancy and poor 
birth outcomes. Disparities in health and particularly in birth outcomes are becoming an 
increasingly large problem in the US, and more research in large, diverse populations is needed 
to fully assess this association in order to better understand risk factors for poor birth outcomes 
and reduce these disparities in health. These studies should examine not only adult exposures in 
the peri-conceptual and prenatal periods but also assess life course and social context to fully 
understand complex interactions, which may vary by race/ethnicity, that affect birth outcomes.  
 
 
 
 
Conclusions 
 
 Depression and other psychosocial risk factors during pregnancy are common and may 
potentially have long-lasting effects on offspring.  Although studies in the U.S. on diverse 
populations are limited, there is a suggestion of an association between maternal 
depression/depressive symptoms in pregnancy and the poor birth outcomes of low birth weight, 
preterm birth, and small for gestational age. Elucidating this association is important because 
these poor birth outcomes have been associated with later chronic disease, and identification of 
risk factors may lead to earlier treatment and prevention. Since both depression in pregnancy and 
poor birth outcomes are more common in certain minority groups, this association may be 
important in understanding health disparities. Current research is insufficient to determine if this 
association differs by race/ethnicity. Further research in large, diverse populations investigating 
 not only peri-conceptual risk factors but also life course and social context are needed to better 
understand this association and disparities in health. 
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Table 1: Systematic Review - Study Characteristics 
 
Study Author, 
Year and 
Location 
 
Study Characteristics and 
Sample Size 
Measure of Depression Assessment of Outcome Comments 
Diego et al. 
(2009) 
 
Miami, FL 
 
Prospective cohort study 
 
N=80 pregnant women 
59% Hispanic, 32% AA, 
9% Caucasian 
SCID, CES-D assessed between 
18-20 wks gestation 
 
40 depressed (defined by 
positive SCID) and 40 non-
depressed 
PTB = gestational age <37wks  
LBW = BW <2500g (Abstracted 
from medical records) 
 
Depressed women had 13% greater 
incidence of PTB (OR 2.61 95% CI 
0.73-9.32)  
 
Depressed women had 15% greater 
incidence of LBW (OR 4.75 95% 
CI 0.94-23.99) 
 
Models adjusted for marital 
status, age, and socioeconomic 
status 
 
Excluded women who were 
taking antidepressants 
Field et al. 
(2008) 
 
Miami, FL 
Prospective cohort study 
 
N=430 pregnant women 
55% Hispanic, 23% AA, 
22% Non-Hispanic White 
SCID, CES-D, STAI, STAXI, 
Daily Hassles assessed at 22 
and 32 wks 
 
20% of women (n=86) 
diagnosed with dysthymia or 
MDD from SCID at 22wks 
 
Self-reported birthweight and 
gestational age at postnatal visit 
 
Depressed women had 1.6 wks less 
gestational age (39.1 vs. 37.5) and 
239g (3332.3 vs. 3093.3) lower 
birthweight on average (both with 
p<0.05) 
 
No multivariate models that 
assessed for confounders 
 
None of the women smoked, 
used illicit drugs, or medication 
for depression 
Field et al. 
(2009) 
 
Miami, FL 
Prospective cohort study 
 
N=336 pregnant Black 
women 
56% AA, 26% Haitian, 
18% Caribbean Black 
SCID, CES-D, STAI, STAXI, 
Daily Hassles, SES/Support 
assessed at 18-22 and 32 wks 
 
205 non-depressed and 131 
depressed women (determined 
by SCID) 
Birthweight and gestational age 
abstracted from medical records 
 
Depressed women had 1.4wks less 
gestational age (39.1 vs. 37.7)and 
65g less BW on average (3310.2 vs. 
3245.7), both significant p=0.05 
Model adjusted for SES, marital 
status and education 
 
Excluded women with drug use, 
complicated pregnancies, other 
psychiatric conditions, or those 
taking antidepressants or 
steroids. 
 
 
 
Hodgkinson et 
al. (2010) 
 
Washington 
DC 
Retrospective cohort study 
 
N=294 pregnant 
adolescents enrolled in 
Teen Alliance for Prepared 
Parenting (TAPP) program 
76% AA and 24% 
Hispanic/Latina 
4-item psychosocial intake form 
to assess depressive symptoms 
and SI/SA 
 
28% of women reported 
depressive symptoms; 17% 
with SI/SA 
Birthweight and gestational age 
abstracted from medical records 
 
Depressed adolescents with SI/SA 
had 239.5g less BW on average 
(p<0.05) than non-depressed 
adolescents 
 
Stratified by race, but no difference 
in depressive symptoms or SI/SA 
between groups 
 
Model adjusted for age, 
prenatal visits, and gestational 
age 
 
None of the adolescents were 
receiving psychotherapy or 
psychopharmacological 
treatment 
Orr et al. 
(1995) 
 
Baltimore, MD 
Prospective cohort study 
 
N=1861 pregnant women 
77% AA and 23% White 
CES-D score at first prenatal 
visit, stratified by upper 10th 
(depression) and lower 90th (no 
depression) 
 
10% of women classified as 
depressed 
PTB = gestational age <37wks 
(Abstracted from medical records) 
 
Differences in rates of PTB by 
depression not present in White 
women but attenuated in Black 
women ( 16.5% in depressed 
women vs. 10.1% in non-depressed, 
p=0.03 in bivariable and p=0.06 in 
logistic regression models) 
 
 Interaction term for race and CES-
D not significant in logistic 
regression models 
 
Models adjusted for low pre-
pregnancy weight, 
hospitalization, HTN, previous 
poor outcome 
Orr et al. 
(2002) 
 
Baltimore, MD 
Prospective cohort study 
 
N=1399 
100% AA 
CES-D score at first prenatal 
visit, stratified by upper 10th 
(depression) and lower 90th (no 
depression) 
 
10% of women classified as 
depressed 
Spontaneous PTB = gestational age 
<37wks abstracted from medical 
records 
 
Adjusted OR for spontaneous PTB 
given elevated CES-D score (10th 
percentile) was 1.96 (95% CI 1.04-
3.72)  
 
Model: Low pre-pregnancy 
BMI and previous poor 
pregnancy outcome also 
associated with PTB after 
adjustment.  Other confounders 
were alcohol, bleeding, drug 
use, and smoking. 
 
 
Phillips et al. 
(2010) 
 
USA 
Nested retrospective cohort 
study (Black Women’s 
Health Study) 
 
N=2627 
100% AA  
CES-D completed at entry into 
study divided into quartiles of 
<16, 16-22, 23-32, and >33 
 
25.9% had scores >=16; 11.0% 
>=23, and 2.9% >=33 
Retrospective self-reporting of PTB 
(3 or more weeks early, 
spontaneous or medically 
indicated). Validated these reports 
against medical records in two 
small groups 
 
Borderline association between 
CES-D >=33 and spont. PTB as 
compared with CES-D <16 OR 2.0 
(0.94-4.25) p=0.09 
 
Model adjusted for age, marital 
status, education, BMI, 
smoking, parity, mother born 
PTB, and comorbid conditions 
 
No significant association with 
spont. PTB at any other CES-D 
levels or with medically 
indicated PTB 
 
Steer et al. 
(1992) 
 
Camden, NJ 
Prospective cohort study 
 
N=323 adolescents and 389 
adults 
28.7% Puerto Rican, 61.8% 
Black, 9.6% White 
Beck Depression Inventory 
(BDI)  at 28 wks 
 
Cutoff of BDI score >21 for 
clinical depression 
PTB = gestational age <37wks  
LBW = bw <2500g 
SGA = less than 10th percentile 
(All abstracted from medical 
records) 
 
For clinically depressed adult 
women, risk of outcomes was: 
LBW OR 3.97 (3.8-4.14), PTB OR 
3.39 (3.24-3.56), and OR SGA 3.02 
(2.88-3.17) 
 
Model adjusted for multiple 
confounders depending on 
outcome.  Of note, models for 
PTB and LBW were adjusted 
for black race/ethnicity 
 
No effect seen with adolescents 
 
*Abbreviations: AA-African-American; SCID-Structured Clinical Interview for Depression ; CES-D-Center’s for Epidemiological Services 
Depression Scale; STAI-State Trait Anxiety Inventory; STAXI-State Trait Anger Expression Inventory; BW-birth weight; LBW-low birth weight; 
PTB-preterm birth; SGA-small for gestational age; SES-socioeconomic status; BMI-Body Mass Index 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Systematic Review - Quality of Studies 
1st Author 
and Study 
Year 
Quality of Design 
(reporting, loss to 
follow-up) 
Quality of 
Exposure 
Assessment 
Quality of Outcome 
Assessment 
Quality of Analysis 
and adjustment for 
confounders 
Overall External 
Validity 
Overall 
Grade 
Diego et al. 
(2009) 
Fair- strict eligibility 
criteria (no smoking, 
drug/SSRI use, or 
pregnancy 
complications; small 
sample size 
Good - used both 
clinical diagnosis 
and validated 
scale; only 
measured at 1 
time-point 
Good - abstracted birth 
weight and gestational 
age from medical records; 
calculated fetal growth 
Fair - adjusted for 
multiple confounders, 
mediation analysis 
with cortisol/CES-D 
scale and birth 
outcomes; small 
sample size 
Fair - very small 
sample with strict 
eligibility criteria 
Fair 
Field et al. 
(2008) 
Fair - recruited in 2nd 
trimester from 
university hospital, 
gaps in reporting; 
large sample size 
Good - SCID, 
CES-D; co-
morbid 
conditions and 
cortisol; 
measured at 2 
time points 
Poor -used self-reported 
birth outcomes at 
postnatal visit (Fatal 
Flaw) 
Poor - did not adjust 
for covariates in 
testing means of 
gestational age and 
bw between dep and 
non groups 
Fair - unclear what 
is the source 
population  
Poor 
Field et al. 
(2009) 
Good - defined 
inclusion/exclusion 
and recruitment 
process; no loss to 
follow-up 
Good - multiple 
measures at 
multiple time 
points 
Good - abstracted data 
from medical records 
after birth 
Good - Multivariate 
models that adjusted 
for SES, marital 
status, and education; 
power analysis 
Fair - stringent 
exclusion criteria 
Good 
Hodgkinson 
et al. (2010) 
Fair - retrospective 
cohort study of 
hospital records 
Poor- non-
validated set of 4 
questions to 
assess depression 
and suicidal 
ideation (Fatal 
Flaw) 
Good - abstracted data 
from medical records 
after birth 
Good - multivariate 
models that adjusted 
for age, prenatal 
visits, and gestational 
age 
Fair - adolescents 
from hospital 
program serving 
low SES women 
Poor 
 
 
1st Author 
and Study 
Year 
Quality of Design 
(reporting, loss to 
follow-up) 
Quality of 
Exposure 
Assessment 
Quality of Outcome 
Assessment 
Quality of Analysis 
and adjustment for 
confounders 
Overall External 
Validity 
Overall 
Grade 
Orr et al. 
(1995) 
Good - prospective 
cohort study, good 
reporting, minimal 
loss to follow-up 
Good - used 
validated scale at 
1 time point; 
stratified at 10th 
percentile 
Good - abstracted data 
from medical records 
after birth; used only 
spontaneous PTB 
Good - multivariate 
logistic analysis to 
adjust for multiple 
confounders 
Fair - all AA, urban 
population with 
high minority 
population 
Good 
Orr et al. 
(2002)  
Good - prospective 
cohort study, good 
reporting, minimal 
loss to follow-up 
Good - used 
validated scale at 
1 time point; 
stratified at 10th 
percentile 
Good - abstracted data 
from medical records 
after birth; used only 
spontaneous PTB 
Good - multivariate 
logistic analysis to 
adjust for multiple 
confounders 
Fair - all AA, urban 
population with 
high minority 
population 
Good 
Phillips et al. 
(2010) 
Fair - retrospective 
cohort study of 
hospital records 
Good-used 
validated scale 
assessed 
prospectively, 
multiple strata 
Poor - self-reported 
outcomes, only validated 
a small subset against 
medical records; used >3 
weeks early as outcome 
instead of more accepted 
definition of <37wks 
(Fatal Flaw) 
Fair - multivariate 
logistic regression 
analysis with multiple 
confounders 
Good - sample 
taken from all AA 
in the U.S.; some 
responder bias 
Poor 
Steer et al. 
(1992) 
Good - prospective 
cohort study, good 
reporting, minimal 
loss to follow-up 
Good - used 
validated scale at 
1 timepoint, 
stratified at 
multiple cutoffs 
Good - well-defined, 
abstracted from medical 
records after birth 
Good - multivariate 
models adjusting for 
multiple confounders, 
large sample size 
Fair - inner city 
population, mostly 
minority women 
Good 
*Abbreviations: AA-African-American; SCID-Structured Clinical Interview for Depression ; CES-D-Center’s for Epidemiological Services 
Depression Scale; SSRI-selective serotonin receptor inhibitors; BW-birth weight; LBW-low birth weight; PTB-preterm birth; SGA-small for 
gestational age; SES-socioeconomic status; BMI-Body Mass Index 
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INTRODUCTION 
Low birthweight (LBW), defined as birthweight <2500 grams, is a common measure of 
overall fetal and maternal health.1 Several lines of evidence suggest that LBW may also function 
as a marker of adult health2, as LBW neonates are at increased risk of coronary heart disease, 
stroke, type 2 diabetes, obesity, and some cancers in adulthood.3-8 This epidemiological evidence 
supports the developmental origin of health and disease (DOHAD) hypothesis, which postulates 
that the adaptive response to prenatal and early postnatal environment can affect disease 
susceptibility in adulthood.6, 9-11 
Prenatal depression has been associated with poor birth outcomes including LBW,12 and a 
growing emphasis has been placed on screening for psychosocial risk factors during pregnancy 
as a strategy to reduce poor birth outcomes.13 Depression is one of the more common psychiatric 
disorders among young adults and is associated with substantial morbidity, particularly during 
pregnancy.14 In the United States (US), the prevalence of depressive symptoms in the antenatal 
period ranges from 10-15% depending on gestational age, race/ethnicity, and socioeconomic 
factors.15 As many as 12.7% of pregnant women experience at least one major depressive 
episode during pregnancy.15 Both maternal depression and these poor birth outcomes 
disproportionately affect Blacks and Hispanics compared to Whites.16-18 Mechanistic insights 
that can guide public health or therapeutic intervention efforts to alleviate this disparity are 
required.  
Hormonal dysregulation due to abnormalities of the hypothalamus-pituitary-adrenal 
(HPA) axis driven by epigenetics has been proposed as a potential explanation for associations 
between maternal depression and LBW.19 Empirical data supportive of epigenetic mechanisms 
underlying these associations have been limited by a lack of epigenetic targets. Studies largely 
target promoter regions of genes, as research on tumor suppressor genes has suggested that 
aberrant methylation at promoter regions may lead to transcriptional silencing.11 However, 
imprinted genes, or parent of origin dependent monoalleleic expression regulated by methylation 
that is established differentially on the two parental chromosomes, may play a role in many 
disease processes.20 Epigenetic changes at cis-acting differentially methylated regions (DMRs) 
that regulate imprinted gene expression are important not only in maintaining the imprinted 
status of these genes but also in controlling their levels of expression.21, 22 Since these 
methylation marks are established before gastrulation, they are maintained in all somatic 
tissues.21, 22 Because these genes occur in clusters,  are enriched for growth regulators, and 
intricately interact to coordinate early growth, methylation alterations at a single DMR may lead 
to changes in the regulation of multiple genes.21, 23, 24 The objectives of this analysis were to 
examine the association between prenatal maternal depressed mood in relation to birthweight and 
to evaluate the role of DNA methylation at nine imprinted regulatory sequences in this 
association. Because the effects of depression may be more severe in Blacks compared to 
Whites25, 26 and epigenetic perturbations may be sex-specific,27, 28 we also examine these 
associations by race/ethnicity of the mother and sex of the offspring. 
METHODS 
Study Participants 
Study participants were identified among pregnant women during their first prenatal visit 
and were recruited as part of the Newborn Epigenetics STudy (NEST).29 Between 2009 and 
2011, pregnant women were recruited from five prenatal clinics with delivery capabilities at 
Duke and Durham Regional hospitals, the only two obstetric facilities serving Durham and 
neighboring counties. Eligibility criteria were age 18 and older and intention to use these 
obstetric facilities for delivery. Exclusion criteria included plans to relinquish custody of the 
child, plans to move from the area in the subsequent three years, and infection with HIV due to 
the limited research on the relationships between HIV, its treatment, and DNA methylation in the 
offspring.   
As of December 2011, 2,548 women had been approached and 1700 (66.6%) consented 
to participate. The 848 women who declined were similar to those who consented with respect to 
age (p=0.70) but different with respect to race/ethnicity (p<0.001), with the group that declined 
more likely to be Asian and Native American but similar with respect to other racial/ethnic 
groups. Of the 1700 women, 396 were withdrawn due to miscarriage (n=109), death of infant 
after birth (n=4), illiteracy (n=1), being underage (n=1), or other (n=21); or refused further 
participation (n=146); or gave birth at an outside hospital (n=114), such that 1304 (76.7%) 
women remained enrolled in the study up to the time of analysis. These analyses are limited to 
the 922 women in whom both depressed mood and parturition data are available. The study 
protocol was approved by the Duke University Institutional Review Board (IRB).     
Data collection 
Assessment of Depressed Mood 
At enrollment (gestational age at visit ranged from 4-32.5 weeks with mean and median 
of 12 and 11 weeks respectively) all pregnant women completed a questionnaire about 
sociodemographic characteristics, maternal lifestyle factors, and health conditions. This included 
an assessment of depressed mood using two measures: a self-reported history of being diagnosed 
with depression at questionnaire completion and a self-reported assessment of depressive 
symptoms over the two weeks preceding the interview using the Centers for Epidemiological 
Studies Depression Scale (CES-D).  The CES-D is a well-validated scale with high internal 
consistency (Cronbach’s alpha coefficient of 0.85 in the general population and 0.90 in 
psychiatric patients), that has also been found to correlate well with other scales, symptoms, and 
life events.30 The scale consists of 20 items that are scored by summation of responses (0=rarely, 
1=some of the time, 2=occasionally or moderately, 3=most or all the time) with a range of 0-60. 
Questions 4 (You felt that you were just as good as other people), 8 (You felt hopeful about the 
future), 12 (You were happy), and 16 (You enjoyed life) were reverse-scored according to 
guidelines.30  
From CES-D scores, women were first dichotomized as either having depressed mood 
(CES-D scale score≥16) or having no depressed mood (<16), according to guidelines.30 Because 
there is no recommended CES-D cutoff for severe depressed mood,30 we further categorized 
depressed mood using a history of depression. Women who self-reported a history of depression 
(checked yes when asked if they currently had depression) and also scored 16 or more points on 
the CES-D were classified as having severe depressed mood.  Women who did not self-identify 
as having a history of depression but scored 16 or more on the CES-D were classified as having 
moderate depressed mood. All women who did not self-identify as having a history of depression 
and also scored below 16 on the CES-D depression scale were classified as no depressed mood.  
Women with missing mood data, defined as one or more missing items (n=390), and the 68 
women who self-identified as having a history of a diagnosis of depression but scored below a 16 
on the CES-D were excluded from this analysis. To assess the reliability of our characterization 
of depressed mood using both the CES-D scale and a history of diagnosis of depression to 
categorize severe depressed mood, we repeated the multivariate logistic regression analysis of 
LBW and depressed mood using the CES-D scale only to categorize degree of depressed mood 
with severe (CES-D scale score of ≥30), moderate (CES-D scale score of 16-29) or no (CES-D 
scale score of <16) depressed mood corresponding to approximately the 90th and 75th percentiles 
of the CES-D scale distribution.  
Birth Outcomes 
Birth outcomes data including birthweight, gestational age at birth, infant sex, and 
delivery mode were abstracted by trained personnel from medical records after delivery. Only 
data from singleton births were included in these analyses. Birthweight was divided into three 
categories: LBW (<2500g), normal weight (2500g-4500g) and high birthweight (>4500g), since 
morbidity increases with birthweight, and >4500g may be a better predictor of neonatal 
morbidity.31 Gestational age at birth was divided into two categories: preterm <37 weeks 
gestation, and term >37 weeks gestation. Delivery mode was defined as either vaginal delivery or 
Cesarian section (C-section). 
Measurement of Co-variables 
Maternal age was calculated as the difference between self-reported birthdate year and 
2011, year when last delivery occurred. Education was self-reported by highest grade or year of 
school completed. Annual household income, marital status, employment status, and parity were 
self-reported. “Black” women self-identified as “Black/African American” or as “Biracial/ 
Multiracial” and had a Black mother, “White” women self-identified as “Non-Hispanic White” 
or “Biracial/Multiracial” and had White mothers,  “Hispanic” women self-identified as “Hispanic 
White” or “Biracial/Multiracial” and had Hispanic mothers and “Other” women self-identified as 
“Asian/Pacific Islander”, “American Indian/Native American”,  or “Other” or if they chose 
“Biracial/Multiracial” and had Biracial mothers or if they did not fall into any other category. 
Smoking status was categorized into three groups: smoking prior to pregnancy only, smoking 
prior and during pregnancy, and no smoking based on responses to the following questions. 
Women who answered that they had smoked at least 100 cigarettes in a lifetime and had smoked 
either in the last six months, during the first trimester, after the LMP (last menstrual period), or at 
the time of interview were classified as having smoked during pregnancy. Women who smoked 
at least 100 cigarettes in their lifetime but had not smoked in the past 6 months, during the 1st 
trimester, since their LMP or at the time of questionnaire completion, were classified as having 
smoked prior to pregnancy only. Women who responded that they had not smoked at least 100 
cigarettes in their lifetime were classified as non-smokers. Alcohol status was classified as 
alcohol use during pregnancy if the woman responded “Yes” to drinking >2 drinks/week in the 
month after last menstrual period, or “Yes” to drinking any alcoholic beverages at the time of 
questionnaire completion. All other women without missing data were classified as alcohol non-
users during pregnancy. Use of prescribed psychotropic medication was defined as responding 
“Yes” to using any of the following in the six months prior to the interview: tranquilizers (n=18), 
antidepressants (n=80), sleeping pills (n=72), or anticonvulsants (n=6). Folic acid use was 
defined as responding “Yes” to using a regular dose multivitamin, a multivitamin with additives, 
prenatal vitamins, or single dose folic acid for at least six of twelve months prior to interview. 
Current maternal body mass index (BMI) was calculated from self-reported weight and height at 
the time of enrollment converted to kilograms and meters using the formula weight in kg/height 
in m2. Maternal BMI at LMP was calculated using self-reported weight at LMP. Health status 
was obtained from responses to a single question (How would you describe your current health?) 
using the responses of excellent, very good, good, fair, and poor. Anxiety was defined as a 
positive response to a single question (Check “yes” for any of the listed ailments you may 
currently have) to the listed ailment of anxiety/panic attacks.  
DNA methylation analysis 
Maternal peripheral blood samples were collected at enrollment and infant cord blood 
specimens were collected at birth. Samples were collected in EDTA-treated tubes and 
centrifuged using standard protocols to allow for collection of plasma and buffy coat for DNA 
extraction (Qiagen; Valencia, CA); samples were stored at -80 degrees C until required. DNA 
was extracted using Puregene reagents according to the manufacturer’s protocol (Qiagen) and 
quantity and quality assessed using a Nanodrop 1000 Spectrophotometer (Thermo Scientific; 
Wilmington, DE). Maternal and infant genomic DNA (800 ng) was modified by treatment with 
sodium bisulfite using the Zymo EZ DNA Methylation kit (Zymo Research; Irvine, CA).  
Bisulfite treatment of denatured DNA converts all unmethylated cytosines to uracils, but leaves 
methylated cytosines unchanged, allowing quantitative definition of cytosine methylation status. 
Pyrosequencing was performed using one of two Pyromark Q96 MD pyrosequencers (Qiagen). 
Nine imprinted DMRs for both mothers and infants were analyzed including: the paternally 
methylated and expressed IGF2 DMR, the paternally methylated H19DMR, the paternally 
methylated gametic MEG3-IG DMR (located intergenic to DLK1 and MEG3) and the paternally 
methylated somatic MEG3 DMR (promoter), the maternally methylated PEG3 DMR, the 
maternally methylated MEST DMR, the maternally methylated PEG10 DMR, the maternally 
methylated NNAT DMR and the maternally methylated PLAGL1 DMR. Pyrosequencing assay 
design, genomic coordinates, assay conditions and assay validation are described in detail 
elsewhere.27, 32 Briefly, assays were designed to query established imprinted gene DMRs using 
the Pyromark Assay Design Software (Qiagen). PCR conditions were optimized to produce a 
single, robust amplification product by adjusting annealing temperature and magnesium chloride 
concentrations. Defined mixtures of fully methylated and unmethylated control DNAs were used 
to show a linear increase in detection of methylation values as the level of input DNA 
methylation increased (Pearson r >0.99 for all DMRs). Once optimal conditions were defined, 
each DMR was analyzed using the same amount of input DNA from each specimen (40 ng, 
assuming complete recovery following bisulfite modification), keeping the thermocycler and 
pyrosequencer constant. Percent methylation for each CpG cytosine was determined using Pyro 
Q-CpG Software (Qiagen).  
Statistical Analysis 
 Pearson’s chi-square tests were performed to compare the distribution of demographic 
and obstetric descriptors among women with severe and moderate depressed mood and those 
with no depressed mood. Variables were selected based on their known or suspected associations 
with either LBW or depressed mood in the population. Multivariate logistic regression models 
were fit to examine the relationship between maternal prenatal depressed mood and LBW, 
adjusting for covariates. Initial models were fit using all variables considered clinically important 
in this association and included maternal age, race/ethnicity, marital status, employment, parity, 
household income, education, maternal health status, maternal BMI at enrollment, maternal BMI 
at last menstrual period, smoking, alcohol use, maternal anxiety, psychotropic use, folic acid use, 
trimester at enrollment, infant sex, delivery mode, and preterm birth. All non-binary variables 
were added to multivariate models using indicator variables. A stepwise approach (exclusion 
p>0.10 and inclusion p<0.09) was used to refine the model, and log likelihood tests were used to 
create the final parsimonious model; with significant covariates parity, education, smoking, 
delivery mode, folic acid use, and preterm birth. We also repeated multivariate logistic 
regression analyses using the CES-D scale only stratified at the 75th and 90th percentile (0-15, 16-
29, >30) for none, moderate, and severe depressed mood. In addition, eighteen high birth weight 
(>4500g) infants were excluded in regression models of depressed mood and birth weight 
because no women with severe depressed mood gave birth to high birth weight infants. 
Among the 508 mother-infant pairs where methylation data for at least one of the nine 
DMRs was available, we examined the extent to which DMR methylation modified the 
association between maternal depressed mood and LBW. These 508 mother-infant pairs were 
similar to the original sample with respect to maternal age (p=0.74), maternal CES-D score 
(p=0.85), and proportion of LBW infants (p=0.81). We first assessed each DMR for normality 
using the Kolmogorov-Smirnov test. We found that with the exception of PLAGL1 (p<0.01), 
PEG3 (p<0.01), MEG3-IG (p<0.01), and PEG10 (p=0.03), all other DMRs were normally 
distributed (p>0.05). Confirmatory analysis for individual CpGs revealed Cronbach’s alphas for 
all DMRs were >0.89 suggesting mean methylation levels for each DMR could be used in 
models. T-tests were calculated to compare DMR methylation differences among LBW 
(<2500grams) and high birth weight (>4500grams) infants, each compared to normal birth 
weight (2500-4500grams) infants, and among women with severe and no depressed mood. 
Wilcoxon- rank sum tests were used for DMRs that were not normally distributed. 
Epidemiologic evidence suggests that although high and low birthweight are both associated 
with poor outcomes in adulthood, mechanisms may differ;33 thus they were compared separately 
with normal birth weight infants. In addition, mean values for all nine DMRs were added 
individually to the model of depressed mood and LBW with covariates described above. DMRs 
that resulted in attenuation of the odds ratio (ORs) between severe depressed mood and LBW by 
>10%, before and after inclusion in the model were considered possible effect modifiers of the 
association between maternal depressed mood and LBW. To explore possible effects of maternal 
methylation status,34 all analyses were repeated with adjustments for maternal methylation status. 
Prior studies have suggested that the effects of depression may be more severe in Blacks and 
those with low socioeconomic status 35, 36 possibly due to increased allostatic load from 
socioeconomic and cultural stressors.25, 37-39  The Dutch Famine studies28 and our own analysis of 
the effects of maternal cigarette smoking27 suggest that epigenetic dysregulation may be sex-
specific. Hence, refined models adjusting for parity, education, smoking, delivery mode, folic 
acid use, and preterm birth were used to examine potential effects of a priori defined 
race/ethnicity and infant sex, and analyses were conducted among three racial/ethnic groups 
(Blacks, Whites and Hispanics) as well as by sex of the offspring. Race/ethnicity specific models 
were adjusted for infant sex, and sex-specific models were adjusted for race/ethnicity. All 
analyses were conducted using STATA 12.0 (StataCorp College Station, TX). 
    
RESULTS 
The distribution of maternal sociodemographic characteristics is summarized in Table 1 
by CES-D and history of depression. The median CES-D scale score was 10, and the mean CES-
D scale score was 12.7, S.D. 9.6. Seven percent (n=90) of pregnant women were classified as 
having severe depressed mood, 24% (n=307) moderate depressed mood, and 872 reported no 
depressed mood. Compared to women with no depressive symptoms, both groups of women 
with depressed mood were more likely to be younger (p<0.01), Black (p<0.01), unmarried 
(p<0.01), unemployed (p<0.01), report poorer health (p<0.01), be of lower income (p<0.01), and 
be enrolled later in gestation (p<0.001). Women with depressed mood were also more likely to 
smoke (p<0.01), have anxiety p<0.01), use psychotropic medications (p<0.01), but not take folic 
acid (p=0.02).  Women at extremes of education, notably those less than high school or having 
been to graduate school, were less likely to have depressed mood (p<0.01). Alcohol use, BMI at 
Last Menstrual Period (LMP), BMI at enrollment, sex of offspring, parity and mode of delivery 
were comparable among women with and without depressed mood (p>0.05).  
Association between Depressed Mood and Birthweight 
Birthweight ranged from 580-5422g, with a mean birthweight of 3285g (SD 574g) and 
median of 3330g. Compared to women with no depressed mood, infants born to women with 
severe (but not moderate) depressed mood were more likely to be LBW (OR 3.6, 95% CI 1.1-
11.4), after adjustment for parity, education, smoking, delivery mode, folic acid use, and preterm 
birth (Table 2). We also found that this association was limited to infants born to Black women 
(OR 7.2, 95% CI 1.8-28.7) and more pronounced in female infants (7.5, 95% CI 1.5-38.9). 
However, the cross-product terms for depressed mood and infant sex and for depressed mood 
and race/ethnicity were not statistically significant (p>0.05). These associations were not 
significantly altered by further adjusting for psychotropic medication use and pre-pregnancy or 
early prenatal maternal BMI, in statistical models. Only 15 infants with completed mood data 
were born with birth weight (>4500g) and 12 of them were born to women without depressed 
mood. Also, no severely depressed Hispanic woman gave birth to a LBW infant in this study.   
DNA methylation in relation to Prenatal Depressed Mood and Birthweight 
To determine the extent to which DNA methylation marks mediated, at least in part, the 
association between maternal depressed mood and birth weight, we computed DNA methylation 
differences among normal birth weight (2500-4500grams), LBW (<2500grams) and high birth 
weight (>4500grams) infants  at nine imprinted gene DMRs (IGF2, H19, MEG3-IG MEG3, 
PEG3, MEST, PEG10, NNAT and PLAGL1). We observed that infants born to women with 
severely depressed mood had 2.4% higher methylation levels at the MEG3 DMR than those born 
to non-depressed women (p=0.02; Figure 1). This difference persisted after adjusting for 
maternal DNA methylation levels, despite correlations between maternal and infant methylation 
profiles at these DMRs (coefficient= 0.18-0.51 depending on DMR). Sex- and race/ethnic-
specific analysis revealed that these differences may be larger in female infants (3.6%, p<0.01), 
and those born to Black women (2.3%, p=0.08). These methylation differences remained 
unaltered after excluding all women who reported using psychotropic medications (n=26).  
Infants born to women reporting severely depressed mood had similar DNA methylation levels 
at the other DMRs examined when compared to infants of women with no depressed mood.  
We also observed a 1.6% lower methylation level at the IGF2 DMR among LBW 
compared to normal birth weight infants (Figure 2) (p=0.06); a difference that may be larger in 
female infants (2.3%, p=0.03) and in those born to Black women (2.0%, p=0.08). Intriguingly, 
high birth weight infants had a 5.9% (p=0.02) higher methylation level at the PLAGL1 DMR and 
a 3.4%, p=0.06 higher level at the PEG10 DMR (Figure 3) compared to normal birth weight 
infants. Despite significant methylation differences at the IGF2, PLAGL1, and PEG10 DMRs by 
birth weight, and significant differences at the MEG3 DMR by maternal mood, inclusion of these 
DMRs into multivariate models did not alter the strength or direction of the association between 
maternal mood and birth weight. In addition, maternal DNA methylation at all the nine DMRs 
was comparable between women with severe and no depressed mood as well as between women 
who gave birth to low or high birthweight infants as compared to normal birthweight infants. 
DISCUSSION 
We examined the association between maternal depressed mood during pregnancy and 
birthweight and the extent to which this association was altered by DNA methylation differences 
for DMRs regulating nine imprinted genes. We found that severe maternal depressed mood was 
associated with a three-fold increase in the risk of LBW, after adjustment for parity, education, 
smoking, delivery mode, folic acid use, and preterm birth. This association appeared to be 
stronger in female infants and those born to Black women. We also found that while DNA 
methylation levels at the MEG3 DMR differed significantly by maternal mood, and at the IGF2 
and PLAGL1 DMRs by infant birth weight, there was no evidence to suggest that the association 
between maternal mood and birthweight was mediated by DNA methylation at the nine DMRs 
examined.    
Findings that maternal depressed mood during pregnancy is associated with LBW is 
consistent with at least six reports in diverse populations40-46 that found magnitudes of 
associations in a similar range and direction. However, potential mechanisms that are amenable 
to prevention are still unknown. Animal studies have implicated epigenetic shifts in the 
Hypothalamus-Pituitary-Adrenal (HPA) axis;6 however, empirical data are limited to CG-rich 
promoter regions of a handful of genes. In rats, high levels of maternal licking and grooming 
have been shown to decrease infant stress responses by dampening HPA axis responses to stress 
through increased glucocorticoid receptor (GR) expression and negative feedback.47, 48 In human 
infants, prenatal exposure to maternal depression/anxious mood was associated with higher 
methylation of NR3C1, hippocampal Growth Receptor(GR) gene, at a predicted binding site 
(NGFI-A);49 higher DNA methylation levels were also associated with increased salivary cortisol 
stress response in infants at 3 months, even after adjustment for maternal SSRI (selective 
serotonin re-uptake inhibitors) antidepressant use. Depressed mood in the 2nd trimester has also 
been associated with decreased maternal and infant DNA methylation at the promoter region of 
the SLC6A4 gene,50 which encodes for the transmembrane serotonin transporter. Studies have 
shown that depressed mothers have higher cortisol levels and lower dopamine/serotonin levels 
and that their infants mirrored their biochemical profiles,51, 52 leading to the hypothesis that poor 
birth outcomes, including LBW, are indirectly mediated through hormonal dysregulation of the 
HPA axis, driven by epigenetic mechanisms. These previous studies, together with our findings 
of associations between depressed mood and birthweight with several DMRs regulating 
imprinted genes, support the idea that plasticity in the complex network of epigenetic regulatory 
elements may play a role. Although epidemiological studies alone cannot establish causation, if 
perturbations in DNA methylation occur early in gestation, as suggested here, it is possible that 
these epigenetic regulatory networks can alter metabolic and physiological states that affect 
growth and development.   
Our findings that lower DNA methylation at some imprinted loci increase the risk of 
LBW are consistent with studies of epigenetic dysregulation in growth restriction. Association 
between severe caloric restriction, 5, 53 persistent DNA methylation differences of a similar 
magnitude at multiple epigenetic targets including IGF2 and MEG328, 53, and poor health 
outcomes, including LBW have been previously reported. Some of these epigenetic changes, 
including at the IGF2 DMR, have been associated with adult-onset colon cancer.54 However, 
investigators reported no DNA methylation differences at IGF2, GNASAS, INSIGF and LEP 
DMRs in a subset of 38 adults born small for gestational age and 75 adults born average for 
gestational age.55 We also have reported lower DNA methylation levels directly associated with 
elevated levels of IGF2 expression,27 protein and birthweight in a cohort of primarily term 
infants.56 However, in this cohort with a large number of preterm and very LBW infants 
(<1500grams), we found lower methylation levels at IGF2 associated with LBW. Guo et al. 
found no significant DNA methylation differences at the IGF2 DMR between 20 SGA children 
and non-SGA controls, although IGF2 mRNA levels were decreased in SGA placentae and that 
one SGA exhibited hypomethylation at the H19 DMR, which may have contributed to growth 
restriction.57 In addition, Koukora et al. examined IGF2 imprinting and expression in placenta 
and found significant loss of imprinting in growth restricted placenta compared to controls that 
correlated with decreased IGF2 mRNA levels; however, this decrease was not significant, and 
expression levels did not correlate with birth weight.58 Although the source of heterogeneity in 
these very small studies is unclear, inconsistent findings may reflect the weakness of the use of 
birthweight as a proxy for a wide range of in utero exposures. It will be important for larger 
studies to clarify relationships between environmental exposures and epigenetic marks within 
subgroups of low or high birth weight infants, as these may be heterogeneous. Because some 
epigenetic mechanisms may be malleable,48 47 they could be important biomarkers for 
identifying high risk pregnant women and children and potentially provide therapeutic targets 
and public heath interventions to reduce LBW and its sequelae. 
Epigenetic targets including IGF2, MEG3, and PLAGL1 have been identified as key 
regulators of placental and fetal growth or development.21, 59, 60 IGF2, in particular, is a well-
studied imprinted region that has been implicated in the control of human growth and 
development, and loss of imprinting may be associated with aberrant expression leading to 
dysregulated growth.21, 61 Moreover, loss of imprinting at the IGF2 DMR has been implicated in 
Beckwith-Wiedemann syndrome (BWS), a disorder characterized by dysregulation of growth 
and development resulting in fetal overgrowth and childhood cancers.62 Two potentially 
important regulatory regions within the MEG3/DLK region have been identified and 
hypothesized to affect growth and development in both the placenta and the body.63 Recently, the 
MEG3/DLK region has also been implicated in tumorigenesis64, neural dysfunction in Rett’s 
Syndrome65, and in human clinically non-functioning pituitary adenomas.66 Moreover, PLAGL1 
has been shown to interact with, and alter expression of a network of imprinted genes, including 
IGF2 and DLK1, which regulate embryonic growth.24 Loss of imprinting at PLAGL1 and bi-
allelic expression has been implicated in Transient Neonatal Diabetes Mellitus 1 (TNDM), a 
disorder in which >95% of patients experience IUGR.67 
This study is one of the largest to examine epigenetic markers in relation to maternal 
depressed mood and birthweight. The study sample encompasses three major ethnic groups in 
the U.S. and uses well accepted measures of depressed mood. In addition, the exposure of 
depressed mood was characterized using a well-validated and consistent scale as well as self-
reports, which mirrors the clinical situation where patients often come to medical attention due to 
self-identification of depressive symptoms.  Moreover, to assess the reliability of our 
characterization of depressed mood, we repeated multivariate models using various cutoffs of the 
CES-D scale (>30, 16-29, <16) to define severe, moderate, and no depressed mood, and results 
were similar to the results reported here using the CES-D scale in conjunction with a self-
reported diagnosis of depression to delineate severe depressed mood.  In addition, multiple 
confounders assessed in our statistical models have plausible association with both depressed 
mood and LBW in both our study sample and the overall population. Of note, the extremes of 
education appeared slightly protective of depressed mood, and one possible explanation is that 
there are differential responses to life events as well as different coping strategies that vary with 
education level. Although some studies have suggested a possible role of selective serotonin 
receptor inhibitors (SSRI) antidepressants in poor birth outcomes, we found no significant effect 
of SSRI or other psychotropic medication use, which is consistent with some 49, 68-70 but not all 
studies.71-76 This is most likely due to the inability to determine if the association with birth 
outcomes is between the degree of depression itself or the psychotropic medications, as severely 
depressed women are more likely to be taking medications.  
Limitations of our study include the small number of LBW infants, which limits the 
power of our study. Larger studies are needed to replicate these intriguing findings. In addition, 
our study is limited by the use of depression at only one time point during pregnancy; however, 
depressive symptoms in different trimesters are highly correlated35 and that there may be a 
threshold effect with susceptibility to poor birth outcomes.36 Moreover, other psychosocial 
elements such as stress, life events, and support networks were not examined. Additionally, the 
study was limited by a small number of Asians and Native Americans who also had a low 
response rate, raising concerns about generalizability of our findings to these population 
subgroups. Although multiple comparisons may be of concern, it is unlikely that this could 
explain identification of three of nine DMRs identified here. In addition, the imprint regulatory 
network (imprintome23) contains many key regulatory clusters that were not examined in this 
study and may play critical roles in this association. Genome-wide studies with high resolution in 
diverse populations will be required to better characterize these epigenetic networks and key 
regulators in order to determine their interactions and effects.  
Conclusion 
 Despite these limitations, our findings support those of other studies that maternal 
depressed mood, a common morbidity during pregnancy, can lead to poor birth outcomes, 
especially in minority populations and female infants. We also identified three regions of 
epigenetic alterations at IGF2, PLAGL1, and MEG3 that may be associated with birthweight 
and/or maternal depressed mood. If replicated in larger studies, these findings could provide 
insights into the mechanisms underlying associations between maternal mood and LBW that 
could either serve as markers to identify at- risk infants for further surveillance, or as potential 
therapeutic targets. 
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Tables and Figures 
 
 
 Table 1: Maternal Demographics by CES-D and History of Depression: NEST 
Variable No Depressed 
Mood 
 (n=872) 
Moderate Depressed 
Mood (n=307) 
Severe Depressed 
Mood (n=90) 
Maternal Age (years)* 
18 to <20 
20 to 29 
30 to 39 
40+ 
Mean age (S.D.) 
 
15 (2%) 
415 (48%) 
402 (46%) 
37 (4%) 
29.6 (5.7) 
 
3 (1%) 
191 (63%) 
97 (32%) 
13 (4%) 
28.1 (6.0) 
 
2 (2%) 
49 (55%) 
37 (41%) 
2 (2%) 
28.7 (5.8) 
Maternal Race/Ethnicity* 
White 
Black 
Hispanic 
Other 
 
297 (34%) 
332 (39%) 
210 (24%) 
28 (3%) 
 
73 (24%) 
150 (49%) 
66 (22%) 
14 (5%) 
 
30 (34%) 
40 (45%) 
17 (19%) 
2 (2%) 
Gestational Age at Enrollment* 
1st Trimester (0-13 weeks) 
2nd Trimester (>13-26 weeks) 
3rd Trimester (>26 weeks) 
 
608 (70%) 
257 (29%) 
1 (<1%) 
 
200 (66%) 
102 (33%) 
2 (1%) 
 
53 (59%) 
34 (38%) 
3 (3%) 
Marital Status* 
Never Married 
Married 
Living with Partner 
Divorced/Separated/Widowed 
Other 
 
196 (23%) 
429 (50%) 
202 (23%) 
17 (2%) 
21 (2%) 
 
120 (40%) 
97 (32%) 
64 (22%) 
10 (3%) 
8 (3%) 
 
28 (32%) 
26 (29%) 
26 (29%) 
8 (9%) 
1 (1%) 
Employment* 
Yes 
No 
 
597 (70%) 
255 (30%) 
 
198 (65%) 
105 (35%) 
 
45 (51%) 
43 (49%) 
Parity 
Nulliparous 
Multiparous 
 
315 (37%) 
541 (63%) 
 
111 (38%) 
184 (62%) 
 
23 (26%) 
66 (74%) 
Household Income* 
$<24,999 
$25,000-$49,999 
$50,000-$100,000 
>$100,000 
 
291 (40%) 
129 (18%) 
191 (26%) 
113 (16%) 
 
148 (60%) 
46 (18%) 
40 (16%) 
16 (6%) 
 
51 (67%) 
14 (18%) 
6 (8%) 
5 (7%) 
Education* 
Less than High School 
High School 
College 
Graduate School 
 
93 (11%) 
264 (31%) 
314 (36%) 
194 (22%) 
 
27 (9%) 
126 (42%) 
105 (35%) 
42 (14%) 
 
8 (9%) 
47 (53%) 
26 (29%) 
8 (9%) 
Maternal Health Status* 
Excellent 
Very Good 
Good 
Fair 
Poor 
 
162 (19%) 
310 (36%) 
327 (38%) 
64 (7%) 
3 (<1%) 
 
25 (8%) 
88 (30%) 
137 (46%) 
44 (15%) 
3 (1%) 
 
3 (3%) 
12 (13%) 
45 (51%) 
24 (27%) 
5 (6%) 
Maternal BMI at enrollment 
<18.5 
18.5-<25 
25-<30 
 
10 (1%) 
237 (35%) 
187 (27%) 
 
2 (1%) 
65 (28%) 
71 (31%) 
 
3 (4%) 
18 (27%) 
21 (31%) 
30-<35 
35-<40 
40+ 
Mean (S.D.) 
143 (21%) 
64 (9%) 
48 (7%) 
28.6 (6.9) 
41 (18%) 
24 (10%) 
27 (12%) 
30.0 (8.2) 
12 (17%) 
5 (7%) 
10 (14%) 
29.8 (8.2) 
Maternal Smoking* 
Smoking prior to pregnancy 
Smoking during pregnancy 
No smoking 
 
105 (12%) 
101 (12%) 
657 (76%) 
 
28 (9%) 
68 (23%) 
203 (68%) 
 
9 (10%) 
42 (47%) 
39 (43%) 
Maternal Alcohol 
Alcohol in pregnancy 
No alcohol in pregnancy 
 
62 (11%) 
523 (89%) 
 
27 (13%) 
184 (87%) 
 
9 (13%) 
63 (87%) 
Maternal Anxiety* 
Anxiety Present  
No Anxiety 
 
32 (4%) 
832 (96%) 
 
20 (7%) 
278 (93%) 
 
45 (51%) 
44 (49%) 
Psychotropics during Pregnancy* 
Yes 
No 
 
52 (6%) 
810 (94%) 
 
28 (9%) 
274 (91%) 
 
33 (37%) 
57 (63%) 
Infant Sex 
Male 
Female 
 
395 (53%) 
354 (47%) 
 
140 (56%) 
111 (44%) 
 
37 (49%) 
39 (51%) 
Delivery Mode 
Vaginal 
C-section 
 
504 (67%) 
245 (33%) 
 
172 (68%) 
80 (32%) 
 
47 (63%) 
28 (37%) 
Folic Acid Use* 
Yes 
No 
 
635 (73%) 
231 (27%) 
 
198 (65%) 
107 (35%) 
 
61 (68%) 
29 (32%) 
*Pearson’s Chi-squared p-value between all three groups of depressed mood <0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Multivariate Model – Depressed Mood and Birthweight, overall and stratified by race/ethnicity and 
infant sex  
Depressed Mood LBW  
(<2500g) 
Normal  
(2500-
4500g) 
High 
Birthweight 
(>4500g) 
Adjusted Odds 
Ratio for LBW 
P-value Interaction 
Term p-
value 
Overall*       
Severe 12 (16%) 62 (84%) 0 (0%) 3.60 (1.14-11.40) 
 
p=0.03  
Moderate 20 (8%) 225 (92%) 3 (1%) 1.44 (0.63-3.29) 
 
P=0.39  
None 38(5%) 694 (95%) 12 (2%) 1.0   
Race/Ethnicity†       
  Whites       
Severe 3 (13%) 21 (87%)  14.56 (0.57-374.17) 
 
p=0.11 P=0.22 
Moderate 3 (5%) 55 (95%)  4.01 (0.20-79.92) 
 
p=0.36  
None 10 (4%) 234 (96%)  1.0   
  Blacks       
Severe 9 (29%) 22 (71%)  7.15 (1.78-28.68) 
 
p<0.01  
Moderate 11 (9%) 106 (91%)  1.41 (0.47-4.21) 
 
p=0.54  
None 19 (7%) 262 (93%)  1.0   
       
Infant Sex ‡       
  Males        
Severe 4 (11%) 32 (89%)  1.51 (0.20-11.38) 
 
p=0.69 P=0.18 
Moderate 12 (9%) 123 (91%)  1.25 (0.41-3.84) 
 
p=0.70  
None 19 (5%) 364 (95%)  1.0   
  Females        
Severe 8 (21%) 30 (79%)  7.52 (1.45-38.89) 
 
p=0.02  
Moderate 8 (7%) 100 (93%)  1.21 (0.27-5.39) 
 
p=0.80  
None 18 (5%) 330 (95%)  1.0   
*Overall model adjusted for parity, education, smoking, delivery mode, folic acid use, and preterm birth.  
†Race/ethnicity-specific models adjusted for parity, education, smoking, delivery mode, folic acid use, preterm birth, and infant 
sex  
‡Sex-specific models adjusted for parity, education, smoking, delivery mode, folic acid use, preterm birth, and race/ethnicity.  
 
 
 
 
 
 
 
 
 
Figure 1: Methylation at MEG3 for Infants of Women with Severe and No Depressed Mood  
 
 
Figure 1: Median and IQR of infant methylation levels at the MEG3 DMR. Overall, MEG3 
DMR methylation levels are higher in infants of women with severe compared to no depressed 
mood, p=0.02. This difference exists in female infants (75.6% vs. 72.0%, p<0.01) and Blacks 
(74.8% vs. 72.5%, p=0.08).   
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Figure 2: Infant Methylation at IGF2 by LBW  
 
 
 
Figure 2: Median and IQR for infant methylation levels at the IGF2 DMR. Overall, mean 
methylation at IGF2 DMR is lower for LBW compared to normal weight infants, 49.5% and 
51.1%, p=0.06. This difference persists among female infants (49.2% vs. 51.5%, p=0.03) and 
Blacks (47.9% vs. 49.9%, p=0.08).  
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Figure 3: Infant Methylation at PLAGL1 and PEG10 for High Birthweight Infants  
  
 
 
Figure 3: Median and IQR of infant methylation levels at the PEG10 and PLAGL1 DMRs for 
high and normal birthweight infants. High birthweight is associated with increased methylation 
at the PLAGL1 DMR, Wilcoxon rank sum p=0.02, and at the PEG10 DMR, Wilcoxon rank sum 
p=0.06.  
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